Nazwa produktu: |
awermektyna A1a, 5-O-demetylo-25-de(1-metylopropylo)-22,23-dihydro-25-(1-metyloetylo)- |
Synonimy |
;składnik B iwermektyny (sub 1b); awermektyna H2B1b; (2aE,4E,8E)-(5'S,6S,6'R,7S,,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradekahydro-20,20b-dihydroksy-6'-izopropylo-5',6,8,19-tetrametylo-17-oksopiro(11,15-metano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioksacyklooktadecyna-13,2'-(2H)piran)-7-yl 2,6-dideoksy-4-O-(2,6-dideoksy-3-O-metylo-alfa-L-arabino-heksopiranozylo)-3-O-metylo-alfa-L-arabino-heksopirana; (2aE,4E,8E)-(5'S,6S,6'R,7S,,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradekahydro-20,20b-dihydroksy-6'-izopropylo-5',6,8,19-tetrametylo-17-oksopiro(11,15-metano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioksacyklooktadecyna-13,2'-(2H)piran)-7-yl 2,6-dideoksy-4-O-(2,6-dideoksy-3-O-metylo-alfa-L-arabino-heksopiranozylo)-3-O-metylo-alfa-L-arabino-heksopiraranozyd; Iwermektyna B1b; UNII-0W28CYI3TU; awermektyna A(sub 1a), 5-O-demetylo-25-de(1-metylopropylo)-22,23-dihydro-25-(1-metyloetylo)-; (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroksy-5',6,8,19-tetrametylo-6'-(1-metyloetylo)-17-okso-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradekahydro-2H,7H-spiro[11,15-metanofuro[4,3,2-pq][2,6]benzodioksacyklooktadeksyno-13,2'-piran]-7-yl 2,6-dideoksy-4-O-(2,6-dideoksy-3-O-metylo-α-L-rybo-heksopiranozylo)-3-O-metylo-α-L-arabino-heksopiranozyd |
Angielska nazwa |
Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)-; Ivermectin component B(sub 1b); Avermectin H2B1b; (2aE,4E,8E)-(5'S,6S,6'R,7S,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradecahydro-20,20b-dihydroxy-6'-isopropyl-5',6,8,19-tetramethyl-17-oxospiro(11,15-methano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-(2H)pyran)-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyran; (2aE,4E,8E)-(5'S,6S,6'R,7S,11R,13R,15S,17aR,20R,20aR,20bS)-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-Tetradecahydro-20,20b-dihydroxy-6'-isopropyl-5',6,8,19-tetramethyl-17-oxospiro(11,15-methano-2H,13H,17H-furo(4,3,2-pq)(2,6)benzodioxacyclooctadecin-13,2'-(2H)pyran)-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside; Ivermectin B1b; UNII-0W28CYI3TU; Avermectin A(sub 1a), 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro-25-(1-methylethyl)-; (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-(1-methylethyl)-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-ribo-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside |
MF |
C47H72O14 |
Masie cząsteczkowej |
861.0662 |
InChI |
InChI=1/C47H72O14/c1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b12-11+,26-14+,31-13+/t25-,27-,29-,30-,32+,33-,34-,35+,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m0/s1 |
Nr CAS |
70209-81-3 |
EINECS |
274-384-5 |
Struktury molekularnej |
|
Gęstość |
1.24g/cm3 |
Temperatura wrzenia |
934.1°C at 760 mmHg |
Współczynnik załamania |
1.566 |
Temperatura zapłonu |
267.2°C |
Ciśnienie pary |
0mmHg at 25°C |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|